FibroGen SG&A Expense (TTM) Analysis

FibroGen Inc (FGEN)

0.7256 +0.03 (+5.01%) USD | NASDAQ | Jul 05, 15:45

SG&A Expense (TTM) Chart

Historical SG&A Expense (TTM) Data

View and export this data back to 2014. Upgrade now.

Date	Value
March 31, 2024	103.80M
December 31, 2023	115.25M
September 30, 2023	125.00M
June 30, 2023	129.32M
March 31, 2023	128.40M
December 31, 2022	124.69M
September 30, 2022	125.46M
June 30, 2022	121.41M
March 31, 2022	123.71M
December 31, 2021	123.92M
September 30, 2021	131.44M
June 30, 2021	56.60M
March 31, 2021	87.58M
December 31, 2020	106.41M
September 30, 2020	114.86M
June 30, 2020	199.67M
March 31, 2020	162.87M
December 31, 2019	135.48M
September 30, 2019	102.62M
June 30, 2019	82.16M

Date	Value
March 31, 2019	70.47M
December 31, 2018	63.81M
September 30, 2018	59.81M
June 30, 2018	57.41M
March 31, 2018	55.78M
December 31, 2017	51.76M
September 30, 2017	50.49M
June 30, 2017	49.19M
March 31, 2017	46.14M
December 31, 2016	46.02M
September 30, 2016	46.40M
June 30, 2016	46.00M
March 31, 2016	45.30M
December 31, 2015	44.36M
September 30, 2015	44.22M
June 30, 2015	43.12M
March 31, 2015	40.96M
December 31, 2014	36.91M
September 30, 2014	32.00M
June 30, 2014	28.75M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (TTM) Range, Past 5 Years

56.60M

Minimum

Jun 2021

199.67M

Maximum

Jun 2020

122.03M

Average

123.92M

Median

Dec 2021

SG&A Expense (TTM) Benchmarks